lobbying_activities: 3966157
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3966157 | 455f86ab-6b7f-44b3-857c-969e1efc374a | Q2 | MARSHALL & POPP, LLC | 401105121 | PFIZER, INC. | 2026 | second_quarter | CPT | Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-09T10:30:11-04:00 |